Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000929638-06-000136
Filing Date
2006-03-29
Accepted
2006-03-29 13:10:16
Documents
11
Group Members
EVAN LEVINE

Document Format Files

Seq Description Document Type Size
1 markcap13d28mar06.htm SC 13D 98180
2 ex7_1.htm EX-99.7(1) 5533
3 ex7_2.htm EX-99.7(2) 144351
4 ex7_3.htm EX-99.7(3) 53147
5 ex7_4.htm EX-99.7(4) 53061
6 ex7_5.htm EX-99.7(5) 77430
7 ex7_6.htm EX-99.7(6) 85465
8 ex7_7.htm EX-99.7(7) 35801
9 ex7_8.htm EX-99.7(8) 34859
10 ex7_9.htm EX-99.7(9) 34862
11 ex7_10.htm EX-99.7(10) 39111
  Complete submission text file 0000929638-06-000136.txt   663904
Mailing Address 321 NORRISTOWN ROAD SUITE 230 AMBLER PA 19002
Business Address 321 NORRISTOWN ROAD SUITE 230 AMBLER PA 19002 2155404206
QUANTRX BIOMEDICAL CORP (Subject) CIK: 0000820608 (see all company filings)

EIN.: 330202574 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-40164 | Film No.: 06717809
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 5173 SEAGROVE PLACE SAN DIEGO CA 92130
Business Address 5173 SEAGROVE PLACE SAN DIEGO CA 92130 858-350-4565
Mark Capital LLC (Filed by) CIK: 0001349042 (see all company filings)

EIN.: 522258188 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D